IMPORTANCE Thirty-day hospital readmissions have substantial direct costs and are increasingly used as a measure of quality care. However, data regarding the risk factors and reasons for readmissions in head and neck cancer surgery reconstruction are lacking.
P reventing hospital readmissions is a growing priority for clinicians, hospitals, and policy makers. Avoidable readmissions are estimated to cost the Center for Medicare & Medicaid Services (CMS) up to $17 billion annually, with nearly 18% of patients requiring readmission within 30 days of discharge. 1, 2 In efforts to improve quality of care and reduce wasteful spending, CMS has instituted financial penalties for hospitals with excess 30-day readmissions after select medical hospitalizations and surgical procedures through the Hospital Readmissions Reduction Program (HRRP). 3 Penalties were levied against nearly 80% of hospitals in 2017 with fines totaling $528 million, representing an increase of $108 million from the prior year. 4 Although head and neck surgeries are not yet subject to such penalties, anticipated expansion in the scope of the program is likely to involve our specialty. Previous research in otolaryngology has identified patients with head and neck cancer as a high-risk group for readmission, with rates ranging from 7.3% to 26.5%.
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Reconstructive surgery with pedicled or free flaps is often required for extensive oncologic defects, with the aim of facilitating optimal functional and aesthetic outcome. Although flap reconstruction adds operative complexity and alters the risk profile for complications after head and neck surgery, 11 its impact on hospital readmissions has not been thoroughly explored. Postoperative risks specific to flap reconstruction, such as graft failure, donor site morbidity, and heightened wound care requirements may predispose these patients to rehospitalization. Furthermore, patients with oncologic defects requiring flap reconstruction tend to have worse preoperative medical status, longer postoperative hospital stays, and more complex supportive care needs, all of which can contribute to readmission. Existing studies on readmissions after these surgeries are sparse and have important methodological limitations including singlecenter design, 12,13 shorter than 30-day postdischarge follow-up, 14, 15 and inability to capture the reasons for readmission. 14, 15 Additionally, no prior work, to our knowledge, has specifically described the financial impact of readmissions after these procedures. The purpose of this study, therefore, is to evaluate the particular risk factors, causes, and financial consequences associated with readmissions in patients undergoing flap reconstruction of head and neck oncologic defects using a population-level database that covers comorbidities, health care costs, and readmissions.
Methods

Data Source
We performed a retrospective cohort study using data from the Nationwide Readmissions Database (NRD) from 2010 to 2014. The NRD is a database of all-payer hospital inpatient stays developed as part of 
Study Cohort
We identified hospital discharges for adult patients (≥18 years of age) who underwent an ablative procedure for a diagnosis of a malignant oropharyngeal, laryngeal, hypopharyngeal, or oral cavity neoplasm from 2010 to 2014 using International Classification of Disease, 9th revision (ICD-9) codes (eTable in the Supplement). We further selected those who underwent subsequent pedicled or free flap reconstruction of the head and neck oncologic defect (eTable in the Supplement). 17 This yielded an initial sample of 12 270 patients. We excluded patients who died during the index admission (n = 203; in-hospital mortality, 1.6%). We further excluded patients who were discharged in December (n = 807) to ensure 30-day follow-up for each index hospitalization and patients with out-of-state residence (n = 1773) to avoid potential loss of follow-up. Thus, the study cohort included 9487 patients.
Study Variables
Patient characteristics included age, sex, primary payer, median household income, relevant comorbidities, and procedures performed at the index admission. Comorbidities were drawn from the Elixhauser comorbidity measures for administrative data. 18 In addition to the Elixhauser comorbidities, we further evaluated the impact of tobacco use (305.1, V15.82) and prior radiation exposure (V15.3).
Admission characteristics included admission source, admission type (elective vs nonelective), discharge destination, and prolonged length of hospital stay (defined as longer than the median length of stay in our cohort). Hospital characteristics included hospital bed number, teaching status, ownership, and safety-net hospital status. Safety-net burden was defined as the percentage of treated patients per hospital with Medicaid or uninsured payer status.
19 Safety-net hospitals were defined as those hospitals in the highest quartile of safetynet burden.
Outcomes Measures
The primary outcome of interest was 30-day all-cause readmissions. We defined a readmission as the CMS defines it, namely a readmission to the same (index) or different (nonindex) hospital within 30 days of discharge from the index hospitalization. Hospital transfers were not considered readmissions. For patients who had multiple readmissions within 30 days, only the first readmission was included. The primary cause of readmission was determined by searching the primary ICD-9 diagnostic codes for each readmission (eTable in the Supplement). Secondary outcomes of interest included patient-, admission-, and hospital-level risk factors for readmission as well as cost of readmission.
Statistical Analysis
We compared index admission characteristics of readmitted and nonreadmitted patients using χ 2 tests for categorical variables and independent t tests for continuous variables. We generated national estimates using survey weights from the NRD. Inpatient costs were converted from NRD charges using the hospital-specific cost-to-charge ratios provided by the NRD, and adjusted for inflation to 2014 dollars using the medical component of the consumer price index.
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Univariate analysis was performed to identify associations between patient-, admission-, and hospital-level factors and the risk of readmission. To assess the independent contribution of each variable to the risk of readmission, variables significantly associated with readmission on univariate analysis (P < .05) were included in the multivariate model. Statistical tests were 2 sided. Statistical significance was indicated by P < .05. Statistical analyses were performed using Stata 14 (StataCorp LLC) in October 2017.
Results
Study Population
A total of 9487 eligible patients were identified who underwent flap reconstruction for a head and neck oncologic defect ( Table 1 and Table 2 ). The median age was 63 years (interquartile range [IQR] , 55-71 years), and the majority of patients were male (71.7%; n = 6798). Most operations were performed at large, teaching hospitals (74.6%; n = 7077). In univariate analysis, compared with patients who were not readmitted within 30 days, those readmitted were more likely to have Medicaid or Medicare insurance status, lower household income, advanced comorbidity, length of stay of 10 days or longer, and nonroutine discharge. Readmitted patients also more commonly had undergone total laryngectomy, pharyngectomy, blood transfusion, and percutaneous gastrostomy placement. No statistically significant differences were noted in patient age, history of prior radiation therapy, or any of the hospital characteristics.
Incidence and Risk Factors for Readmission
Among 9487 included patients, 1839 (19.4%) were readmitted within 30 days. Readmissions to a hospital other than the initial treating facility accounted for 26.3% (n = 484) of all readmissions. After controlling for other covariates, factors significantly associated with increased odds of readmission were median household income in the lowest quartile (vs highest quartile: odds ratio [OR], 1.58; 95% CI, 1.18-2.11), congestive heart failure (OR, 1.68; 95% CI, 1.14-2.47), liver disease (OR, 2.02; 95% CI, 1.22-3.33), total laryngectomy (OR, 1.40; 95% CI, 1.12-1.75), pharyngectomy (OR, 1.47; 95% CI, 1.08-2.01), blood transfusion (OR, 1.30; 95% CI, 1.04-1.64), discharge to home with home health care (vs routine: OR, 1.32; 95% CI, 1.04-1.67), and discharge to a nursing facility (vs routine: OR, 1.77; 95% CI, 1.30-2.40) ( Table 3) .
Timing, Causes, and Costs of Readmission
The distribution of time to first readmission is shown in Figure 1 . Median time to readmission was 9 days (IQR, 4-19 days). Median length of stay for readmissions was 5 days (IQR, 3-9 days) compared with 10 days (IQR, 7-17 days) for the index admission. The rate of mortality for the readmission hospitalization was 3.9%.
Causes of 30-day readmission are shown in Figure 2A . Wound complications were the most common reason for readmission, accounting for 26.5% (n = 487) of readmissions (surgical site infection [SSI], 13.6% [n = 250]; fistula, 6.6% [n = 121]; dehiscence, 6.3% [n = 116]). Other medical diagnoses were the second most common cause of readmissions (15.7%; n = 289). Sepsis/septicemia resulted in 7.3% of readmissions (n = 134) and head and neck cancer diagnoses accounted for 5.7% (n = 105) of readmissions. Pneumonia and tracheostomy complications were identified as the primary cause of readmission in 5.5% (n = 101) and 4.3% (n = 79) of patients, respectively. Among early readmissions (≤14 days after discharge), wound complications remained the most common reason for readmission (31.8%; n = 374), although for late readmissions (15-30 days after discharge), other medical diagnoses were more common (18.6%; n = 122) ( Figure 2A ).
The total aggregate costs of all 30-day readmissions were $29.27 million. The mean cost per readmission was $15 916, and median cost was $10 029 (IQR, $5273-$19 029). The mean cost of the index admission was $48 088, and median cost was $39 866 (IQR, $25 840-$60 454). Cost of the first 30-day readmission accounted for 22.9% of the total cost of the episode of care (index admission + readmission) among readmitted patients. There was no significant difference in cost between a readmission to the index hospital or to a different hospital. When stratified by reason for readmission, graft complications ($35 749; standard error of the mean [SEM], $11 019) and respiratory failure ($30 606; SEM, $4561) led to the costliest readmissions, while tracheostomy complications ($11 697; SEM, $1830) and electrolyte/nutrition problems ($9070; SEM, $1769) were the least costly ( Figure 2B ). Furthermore, case complexity, patient factors, and thresholds for readmitting patients after postdischarge complications likely vary across institutions; thus, the generalizability of these studies may be limited. To our knowledge, the present study uses the largest nationwide data set of head and neck flap reconstruction readmissions to index and nonindex hospitals within 30 days of discharge; it provides the most reliable existing baseline value for rehospitalizations after these operations.
Reasons for Readmission
In the present cohort, wound complications were the most common reason for 30-day readmissions, which supports prior studies of major ablative 6 and reconstructive surgery 12 of the upper aerodigestive tract. The risk of surgical site complications after head and neck reconstruction is thought to be higher than for other anatomic sites because of factors including the formation of communication between the upper aerodigestive tract and the neck, contamination from salivary and respiratory secretions, and the relative inaccessibility of certain head and neck sites such as the larynx and pharynx to local wound care. 12,25 Antibiotic prophylaxis and postoperative wound care practices vary widely among reconstructive surgeons. 26 Therefore, this may represent a potential area for quality improvement. More aggressive predischarge evaluation of surgical sites may detect brewing wound infections or identify at-risk patients who may benefit from closer followup. Late-onset infections (>14 days after surgery) represent a considerable portion of flap SSIs (35%-39%) 27,28 and likely pose a greater threat for readmission than early infections, which may be detected before discharge. While early-onset flap SSIs are generally thought to develop from the patient's own oral or skin flora introduced to the wound during surgery, lateonset flap SSIs may be caused by bacteria acquired through secondary contamination of the intraoral wound postoperatively. Given that oral flora change quickly during hospitalization, 29,30 late-onset SSIs due to bacteria acquired several days after surgery may not be prevented by perioperative antibiotics. Longer courses of perioperative antibiotics, which one might consider as a potential solution, have not effectively prevented infection and may actually increase them. 31, 32 An additional prophylactic pulse of antibiotics (eg, <24 hours) given about 7 days postoperatively targeting pathogens in oral flora cultures 4 to 5 days postoperatively has been suggested as a means to further decrease late-onset SSIs.
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In the present study, wound complications were the most common reason for early readmissions (≤14 days after discharge), but other medical diagnoses were more common for late readmissions (15-30 days after discharge). This suggests that potentially a shorter postdischarge interval may be more observed a 3-fold reduction in intensive-care unit admission and mortality from high-risk orthopedic surgery after implementing a multidisciplinary preoperative assessment with an anesthesiologist, surgeon, and nurse practitioner. Such encounters may involve medication adjustment, additional radiologic or laboratory examinations, or further patient education. Nurse-led preoperative assessments have also been shown to decrease patient anxiety, a risk factor that has been associated with unplanned readmissions in prior research.
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Lower median household income was a significant risk factor for 30-day readmission. Socioeconomically disadvantaged patients tend to present with more advanced disease, 36 have greater rates of nonadherence to medication regimens and lifestyle restrictions, 37 and may have difficulty affording care supplies or accessing other resources needed to manage postoperative problems. Increased attention to discharge planning and coordination of postdischarge care is warranted in this particularly high-risk demographic.
Patients who underwent ablative surgeries that included total laryngectomy or pharyngectomy prior to reconstruction had increased odds of readmission. These operations transgress anatomic structures essential to speech, breathing, and swallowing. Resultant physiologic changes can be lifealtering, often requiring the placement of a tracheostomy or gastrostomy tube, and impose a substantial burden on patients and caretakers in the early postoperative period. Graboyes et al 10 found that most emergency department visits after total laryngectomy were related to the laryngectomy stoma or tracheoesophageal puncture, and that emergency department visits predicted a 5-fold increased risk of readmission. Flap reconstruction introduces further challenges to the airway management of these patients because obstruction via oropharyngeal edema, swelling of the flap, or hemorrhage can be life-threatening and require urgent action. While flap failure and wound complications have received the most attention in the microvascular literature (and justifiably so), the need for increased supportive care has also represented a substantial portion (15%-20%) 12,13 of reasons for readmission in prior case series, including the present study, and deserve further investigation. Greater emphasis on stomal care, potentially through formal predischarge evaluations, may be beneficial at reducing these hospital revisits. Studies comparing the efficacy of different strategies for patient and family education are lacking and, when conducted, may provide the foundation for standards of care to guide clinicians and caregivers.
Limitations
The current study is not without limitations. The use of administrative data relies on ICD-9 coding practices, which may vary among clinicians and administrative staff or contain coding errors. However, the ICD-9 coding system has been frequently used and validated to identify the diagnoses and procedures defined in our study. 17, 21, 38 The primary diagnosis codes of a readmission may not always correlate with the true reason for readmission. We were unable to reliably separate planned and unplanned readmissions. Additionally, the ICD-9 code for flap reconstruction does not differentiate between microvascular and pedicled flap reconstruction. Finally, the NRD does not contain tumor-specific information, which prevented us from adjusting for cancer stage or pathologic characteristics in our analysis.
Conclusions
In the first national database analysis to our knowledge to capture 30-day readmissions to primary and outside hospitals after flap reconstruction for head and neck oncologic defects, we demonstrate that approximately 1 in 5 patients is readmitted within 30 days. Readmissions are most commonly associated with wound complications and occur early after discharge. Significant risk factors for readmission include lower socioeconomic status, complex ablative procedures, and certain patient comorbidities. These findings may be useful to clinicians in developing preoperative initiatives to improve medical optimization of high-risk patients and postoperative protocols aimed to reduce hospital readmissions and improve quality of patient care.
eTable 1. ICD-9 Procedure and Diagnosis Codes Procedures
ICD-9 Codes
Pedicled or free flap reconstruction 86.7, 86.70, 86.71, 86.72, 86.73, 86.74, 86.75, 86.8, 86 .89
Ablative Procedures
Oral cavity excision/ destruction of lesion 25. 1, 27.3, 27.31, 27.4, 27.42, 27.43, 27 1, 140.3, 140.4, 140.6, 140.8, 140.9, 141.1, 141.2, 141.3, 141.4, 141.9, 143.0, 143.1, 143.8, 143.9, 144.0, 144.4, 144.8, 144.9, 145.0, 145.1, 145.2, 145.5, 145.6, 145.8, 145.9, 170.1 Oropharyngeal neoplasm (malignant) 141. 0, 141.5, 141.6, 141.8, 145.3, 145.4, 146.0, 146.1, 146.2, 146.3, 146.6, 146.7, 146.8, 146.9, 149.0, 149.1 Laryngeal neoplasm (malignant) 161.0, 161. 1, 161.2, 161.3, 161.8, 161.9, 146.4, 146.5 
